corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 1936

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Shuchman M.
The Olivieri dispute: no end in sight?
CMAJ 2002 Feb 19; 166:(4):487
http://www.cmaj.ca/cgi/content/full/166/4/487, http://www.cmaj.ca/cgi/reprint/166/4/487.pdf


Abstract:

The newsmaking potential of the Olivieri story reflects larger questions. Do drug companies silence researchers? Have academic institutions put their interest in wealthy donors above all others? Are research subjects adequately protected? The deliberation of several groups has put Olivieri back in the spotlight. In October, three professors released a report commissioned by the Canadian Association of University Teachers. It largely favours Olivieri. The professors also called for changes in Canada’s Food and Drugs Act and recommended that hospitals change how they investigate physicians. Olivieri says the report has fully vindicated her. HSC responded to the report, saying it had implemented new research policies, adding: “This dispute is closed and attempts to revive it are counterproductive.” In 1999 Olivieri and two colleagues complained to the College of Physicians and Surgeons of Ontario about Gideon Koren, an HSC doctor who sent them “poison-pen” letters. In November, the Health Professions Appeal and Review Board ordered CPSO to refer the case for a disciplinary hearing. In December, CPSO decided in Olivieri’s favour on alleged ethical transgressions. Shortly after, HSC told Olivieri it would not take the investigation further. Although Olivieri appears to have won her battles with Apotex, HSC and UT, she and her supporters are still pursuing grievances against UT and ongoing litigation with Apotex. In her newspaper commentary on the CAUT report, she concluded: “Not one of us believes that the report represents the end of this struggle”

Keywords:
news story Canada Olivieri Apotex University of Toronto conflict-of-interest ETHICAL ISSUES IN PROMOTION: ETHICS OF TRIALS PROMOTION DISGUISED: DISINFORMATION AND HARASSMENT SPONSORSHIP: RESEARCH

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909